id	sid	tid	token	lemma	pos
aiua-6465	1	1	83archivio	83archivio	NUM
aiua-6465	1	2	italiano	italiano	PROPN
aiua-6465	1	3	di	di	X
aiua-6465	1	4	urologia	urologia	PROPN
aiua-6465	1	5	e	e	PROPN
aiua-6465	1	6	andrologia	andrologia	NOUN
aiua-6465	1	7	2017	2017	NUM
aiua-6465	1	8	;	;	PUNCT
aiua-6465	1	9	89	89	NUM
aiua-6465	1	10	,	,	PUNCT
aiua-6465	1	11	1	1	NUM
aiua-6465	1	12	case	case	NOUN
aiua-6465	1	13	report	report	VERB
aiua-6465	1	14	b	b	X
aiua-6465	1	15	-	-	PUNCT
aiua-6465	1	16	lymphocytic	lymphocytic	ADJ
aiua-6465	1	17	infiltration	infiltration	NOUN
aiua-6465	1	18	of	of	ADP
aiua-6465	1	19	the	the	DET
aiua-6465	1	20	prostate	prostate	NOUN
aiua-6465	1	21	to	to	ADP
aiua-6465	1	22	a	a	DET
aiua-6465	1	23	patient	patient	NOUN
aiua-6465	1	24	with	with	ADP
aiua-6465	1	25	chronic	chronic	ADJ
aiua-6465	1	26	lymphocytic	lymphocytic	ADJ
aiua-6465	1	27	leukemia	leukemia	NOUN
aiua-6465	1	28	.	.	PUNCT
aiua-6465	2	1	a	a	DET
aiua-6465	2	2	case	case	NOUN
aiua-6465	2	3	report	report	NOUN
aiua-6465	2	4	ioannis	ioannis	PROPN
aiua-6465	2	5	anastasiou	anastasiou	PROPN
aiua-6465	2	6	,	,	PUNCT
aiua-6465	2	7	spyridon	spyridon	ADJ
aiua-6465	2	8	skoufias	skoufias	PROPN
aiua-6465	2	9	,	,	PUNCT
aiua-6465	2	10	ioannis	ioannis	PROPN
aiua-6465	2	11	katafigiotis	katafigiotis	PROPN
aiua-6465	2	12	,	,	PUNCT
aiua-6465	2	13	ioannis	ioannis	PROPN
aiua-6465	2	14	skarmoutsos	skarmoutsos	PROPN
aiua-6465	2	15	,	,	PUNCT
aiua-6465	2	16	constantinos	constantinos	PROPN
aiua-6465	2	17	a.	a.	NOUN
aiua-6465	2	18	constantinides	constantinide	VERB
aiua-6465	2	19	1	1	NUM
aiua-6465	2	20	1st	1st	ADJ
aiua-6465	2	21	university	university	NOUN
aiua-6465	2	22	urology	urology	NOUN
aiua-6465	2	23	clinic	clinic	NOUN
aiua-6465	2	24	,	,	PUNCT
aiua-6465	2	25	laiko	laiko	ADJ
aiua-6465	2	26	hospital	hospital	NOUN
aiua-6465	2	27	,	,	PUNCT
aiua-6465	2	28	athens	athens	PROPN
aiua-6465	2	29	,	,	PUNCT
aiua-6465	2	30	greece	greece	PROPN
aiua-6465	2	31	.	.	PUNCT
aiua-6465	3	1	involvement	involvement	NOUN
aiua-6465	3	2	of	of	ADP
aiua-6465	3	3	the	the	DET
aiua-6465	3	4	prostate	prostate	NOUN
aiua-6465	3	5	gland	gland	NOUN
aiua-6465	3	6	,	,	PUNCT
aiua-6465	3	7	as	as	ADP
aiua-6465	3	8	an	an	DET
aiua-6465	3	9	early	early	ADJ
aiua-6465	3	10	extra	extra	ADJ
aiua-6465	3	11	-	-	ADJ
aiua-6465	3	12	nodal	nodal	ADJ
aiua-6465	3	13	manifestation	manifestation	NOUN
aiua-6465	3	14	of	of	ADP
aiua-6465	3	15	a	a	DET
aiua-6465	3	16	hematologic	hematologic	NOUN
aiua-6465	3	17	disease	disease	NOUN
aiua-6465	3	18	,	,	PUNCT
aiua-6465	3	19	or	or	CCONJ
aiua-6465	3	20	as	as	SCONJ
aiua-6465	3	21	a	a	DET
aiua-6465	3	22	secondary	secondary	ADJ
aiua-6465	3	23	infiltration	infiltration	NOUN
aiua-6465	3	24	is	be	AUX
aiua-6465	3	25	rare	rare	ADJ
aiua-6465	3	26	.	.	PUNCT
aiua-6465	4	1	even	even	ADV
aiua-6465	4	2	rarer	rarer	ADV
aiua-6465	4	3	is	be	AUX
aiua-6465	4	4	the	the	DET
aiua-6465	4	5	acute	acute	ADJ
aiua-6465	4	6	urinary	urinary	ADJ
aiua-6465	4	7	retention	retention	NOUN
aiua-6465	4	8	due	due	ADP
aiua-6465	4	9	to	to	ADP
aiua-6465	4	10	infiltration	infiltration	NOUN
aiua-6465	4	11	by	by	ADP
aiua-6465	4	12	lymphocytes	lymphocyte	NOUN
aiua-6465	4	13	and	and	CCONJ
aiua-6465	4	14	simultaneously	simultaneously	ADV
aiua-6465	4	15	enlarged	enlarge	VERB
aiua-6465	4	16	prostate	prostate	NOUN
aiua-6465	4	17	.	.	PUNCT
aiua-6465	5	1	we	we	PRON
aiua-6465	5	2	present	present	VERB
aiua-6465	5	3	a	a	DET
aiua-6465	5	4	case	case	NOUN
aiua-6465	5	5	of	of	ADP
aiua-6465	5	6	a	a	DET
aiua-6465	5	7	61	61	NUM
aiua-6465	5	8	years	year	NOUN
aiua-6465	5	9	old	old	ADJ
aiua-6465	5	10	male	male	ADJ
aiua-6465	5	11	patient	patient	NOUN
aiua-6465	5	12	with	with	ADP
aiua-6465	5	13	a	a	DET
aiua-6465	5	14	history	history	NOUN
aiua-6465	5	15	of	of	ADP
aiua-6465	5	16	chronic	chronic	ADJ
aiua-6465	5	17	lymphocytic	lymphocytic	ADJ
aiua-6465	5	18	leukemia	leukemia	NOUN
aiua-6465	5	19	,	,	PUNCT
aiua-6465	5	20	who	who	PRON
aiua-6465	5	21	was	be	AUX
aiua-6465	5	22	under	under	ADP
aiua-6465	5	23	oncological	oncological	ADJ
aiua-6465	5	24	follow	follow	NOUN
aiua-6465	5	25	-	-	PUNCT
aiua-6465	5	26	up	up	NOUN
aiua-6465	5	27	with	with	ADP
aiua-6465	5	28	no	no	DET
aiua-6465	5	29	active	active	ADJ
aiua-6465	5	30	treatment	treatment	NOUN
aiua-6465	5	31	and	and	CCONJ
aiua-6465	5	32	had	have	VERB
aiua-6465	5	33	typical	typical	ADJ
aiua-6465	5	34	lower	low	ADJ
aiua-6465	5	35	urinary	urinary	ADJ
aiua-6465	5	36	tract	tract	NOUN
aiua-6465	5	37	symptoms	symptom	NOUN
aiua-6465	5	38	due	due	ADJ
aiua-6465	5	39	to	to	ADP
aiua-6465	5	40	benign	benign	ADJ
aiua-6465	5	41	prostatic	prostatic	ADJ
aiua-6465	5	42	hyperplasia	hyperplasia	NOUN
aiua-6465	5	43	and	and	CCONJ
aiua-6465	5	44	was	be	AUX
aiua-6465	5	45	receiving	receive	VERB
aiua-6465	5	46	5	5	NUM
aiua-6465	5	47	-	-	PUNCT
aiua-6465	5	48	alpha	alpha	NOUN
aiua-6465	5	49	reductase	reductase	NOUN
aiua-6465	5	50	inhibitor	inhibitor	NOUN
aiua-6465	5	51	.	.	PUNCT
aiua-6465	6	1	after	after	ADP
aiua-6465	6	2	an	an	DET
aiua-6465	6	3	acute	acute	ADJ
aiua-6465	6	4	urinary	urinary	ADJ
aiua-6465	6	5	retention	retention	NOUN
aiua-6465	6	6	episode	episode	NOUN
aiua-6465	6	7	which	which	PRON
aiua-6465	6	8	was	be	AUX
aiua-6465	6	9	managed	manage	VERB
aiua-6465	6	10	with	with	ADP
aiua-6465	6	11	a	a	DET
aiua-6465	6	12	suprapubic	suprapubic	ADJ
aiua-6465	6	13	catheter	catheter	NOUN
aiua-6465	6	14	due	due	ADP
aiua-6465	6	15	to	to	ADP
aiua-6465	6	16	urethral	urethral	ADJ
aiua-6465	6	17	catheter	catheter	NOUN
aiua-6465	6	18	insertion	insertion	NOUN
aiua-6465	6	19	failure	failure	NOUN
aiua-6465	6	20	,	,	PUNCT
aiua-6465	6	21	the	the	DET
aiua-6465	6	22	patient	patient	NOUN
aiua-6465	6	23	was	be	AUX
aiua-6465	6	24	submitted	submit	VERB
aiua-6465	6	25	to	to	ADP
aiua-6465	6	26	a	a	DET
aiua-6465	6	27	transurethral	transurethral	ADJ
aiua-6465	6	28	prostatectomy	prostatectomy	NOUN
aiua-6465	6	29	.	.	PUNCT
aiua-6465	7	1	histological	histological	ADJ
aiua-6465	7	2	examination	examination	NOUN
aiua-6465	7	3	revealed	reveal	VERB
aiua-6465	7	4	lymphocytic	lymphocytic	ADJ
aiua-6465	7	5	infiltration	infiltration	NOUN
aiua-6465	7	6	of	of	ADP
aiua-6465	7	7	the	the	DET
aiua-6465	7	8	prostatic	prostatic	ADJ
aiua-6465	7	9	parenchyma	parenchyma	NOUN
aiua-6465	7	10	by	by	ADP
aiua-6465	7	11	mostly	mostly	ADV
aiua-6465	7	12	small	small	ADJ
aiua-6465	7	13	b	b	NOUN
aiua-6465	7	14	cells	cell	NOUN
aiua-6465	7	15	.	.	PUNCT
aiua-6465	8	1	b	b	X
aiua-6465	8	2	-	-	PUNCT
aiua-6465	8	3	lymphocytic	lymphocytic	ADJ
aiua-6465	8	4	infiltration	infiltration	NOUN
aiua-6465	8	5	of	of	ADP
aiua-6465	8	6	the	the	DET
aiua-6465	8	7	prostate	prostate	NOUN
aiua-6465	8	8	gland	gland	NOUN
aiua-6465	8	9	,	,	PUNCT
aiua-6465	8	10	causes	cause	VERB
aiua-6465	8	11	symptoms	symptom	NOUN
aiua-6465	8	12	similar	similar	ADJ
aiua-6465	8	13	to	to	ADP
aiua-6465	8	14	benign	benign	ADJ
aiua-6465	8	15	prostatic	prostatic	ADJ
aiua-6465	8	16	hyperplasia	hyperplasia	NOUN
aiua-6465	8	17	.	.	PUNCT
aiua-6465	9	1	acute	acute	ADJ
aiua-6465	9	2	urinary	urinary	ADJ
aiua-6465	9	3	retention	retention	NOUN
aiua-6465	9	4	due	due	ADP
aiua-6465	9	5	to	to	ADP
aiua-6465	9	6	b	b	NOUN
aiua-6465	9	7	-	-	PUNCT
aiua-6465	9	8	lymphocytic	lymphocytic	ADJ
aiua-6465	9	9	infiltration	infiltration	NOUN
aiua-6465	9	10	of	of	ADP
aiua-6465	9	11	the	the	DET
aiua-6465	9	12	prostate	prostate	NOUN
aiua-6465	9	13	is	be	AUX
aiua-6465	9	14	rare	rare	ADJ
aiua-6465	9	15	and	and	CCONJ
aiua-6465	9	16	the	the	DET
aiua-6465	9	17	diagnosis	diagnosis	NOUN
aiua-6465	9	18	is	be	AUX
aiua-6465	9	19	always	always	ADV
aiua-6465	9	20	histological	histological	ADJ
aiua-6465	9	21	and	and	CCONJ
aiua-6465	9	22	an	an	DET
aiua-6465	9	23	oncological	oncological	ADJ
aiua-6465	9	24	re	re	NOUN
aiua-6465	9	25	-	-	NOUN
aiua-6465	9	26	evaluation	evaluation	NOUN
aiua-6465	9	27	is	be	AUX
aiua-6465	9	28	necessary	necessary	ADJ
aiua-6465	9	29	.	.	PUNCT
aiua-6465	10	1	the	the	DET
aiua-6465	10	2	prognosis	prognosis	NOUN
aiua-6465	10	3	of	of	ADP
aiua-6465	10	4	these	these	DET
aiua-6465	10	5	patients	patient	NOUN
aiua-6465	10	6	is	be	AUX
aiua-6465	10	7	related	relate	VERB
aiua-6465	10	8	to	to	ADP
aiua-6465	10	9	the	the	DET
aiua-6465	10	10	generalized	generalized	ADJ
aiua-6465	10	11	disease	disease	NOUN
aiua-6465	10	12	rather	rather	ADV
aiua-6465	10	13	than	than	ADP
aiua-6465	10	14	to	to	ADP
aiua-6465	10	15	the	the	DET
aiua-6465	10	16	prostatic	prostatic	ADJ
aiua-6465	10	17	involvement	involvement	NOUN
aiua-6465	10	18	.	.	PUNCT
aiua-6465	11	1	key	key	ADJ
aiua-6465	11	2	words	word	NOUN
aiua-6465	11	3	:	:	PUNCT
aiua-6465	11	4	b	b	X
aiua-6465	11	5	-	-	PUNCT
aiua-6465	11	6	lymphocytic	lymphocytic	ADJ
aiua-6465	11	7	infiltration	infiltration	NOUN
aiua-6465	11	8	;	;	PUNCT
aiua-6465	11	9	prostate	prostate	NOUN
aiua-6465	11	10	;	;	PUNCT
aiua-6465	11	11	chronic	chronic	ADJ
aiua-6465	11	12	lymphocytic	lymphocytic	ADJ
aiua-6465	11	13	leukemia	leukemia	NOUN
aiua-6465	11	14	.	.	PUNCT
aiua-6465	12	1	submitted	submit	VERB
aiua-6465	12	2	12	12	NUM
aiua-6465	12	3	december	december	PROPN
aiua-6465	12	4	2016	2016	NUM
aiua-6465	12	5	;	;	PUNCT
aiua-6465	12	6	accepted	accept	VERB
aiua-6465	12	7	11	11	NUM
aiua-6465	12	8	january	january	PROPN
aiua-6465	12	9	2017	2017	NUM
aiua-6465	12	10	summary	summary	NOUN
aiua-6465	12	11	no	no	DET
aiua-6465	12	12	conflict	conflict	NOUN
aiua-6465	12	13	of	of	ADP
aiua-6465	12	14	interest	interest	NOUN
aiua-6465	12	15	declared	declare	VERB
aiua-6465	12	16	.	.	PUNCT
aiua-6465	13	1	diagnosed	diagnose	VERB
aiua-6465	13	2	seven	seven	NUM
aiua-6465	13	3	years	year	NOUN
aiua-6465	13	4	ago	ago	ADV
aiua-6465	13	5	,	,	PUNCT
aiua-6465	13	6	without	without	ADP
aiua-6465	13	7	receiving	receive	VERB
aiua-6465	13	8	any	any	DET
aiua-6465	13	9	treatment	treatment	NOUN
aiua-6465	13	10	underwent	underwent	NOUN
aiua-6465	13	11	transurethral	transurethral	ADJ
aiua-6465	13	12	resection	resection	NOUN
aiua-6465	13	13	of	of	ADP
aiua-6465	13	14	prostate	prostate	NOUN
aiua-6465	13	15	adenoma	adenoma	ADV
aiua-6465	13	16	.	.	PUNCT
aiua-6465	14	1	the	the	DET
aiua-6465	14	2	patient	patient	NOUN
aiua-6465	14	3	had	have	VERB
aiua-6465	14	4	lower	low	ADJ
aiua-6465	14	5	urinary	urinary	ADJ
aiua-6465	14	6	tract	tract	NOUN
aiua-6465	14	7	symptoms	symptom	NOUN
aiua-6465	14	8	during	during	ADP
aiua-6465	14	9	the	the	DET
aiua-6465	14	10	last	last	ADJ
aiua-6465	14	11	months	month	NOUN
aiua-6465	14	12	due	due	ADP
aiua-6465	14	13	to	to	ADP
aiua-6465	14	14	benign	benign	ADJ
aiua-6465	14	15	prostate	prostate	NOUN
aiua-6465	14	16	hyperplasia	hyperplasia	NOUN
aiua-6465	14	17	and	and	CCONJ
aiua-6465	14	18	was	be	AUX
aiua-6465	14	19	receiving	receive	VERB
aiua-6465	14	20	treatment	treatment	NOUN
aiua-6465	14	21	with	with	ADP
aiua-6465	14	22	dutasteride	dutasteride	NOUN
aiua-6465	14	23	(	(	PUNCT
aiua-6465	14	24	5	5	NUM
aiua-6465	14	25	-	-	PUNCT
aiua-6465	14	26	a	a	DET
aiua-6465	14	27	reductase	reductase	NOUN
aiua-6465	14	28	inhibitor	inhibitor	NOUN
aiua-6465	14	29	)	)	PUNCT
aiua-6465	14	30	.	.	PUNCT
aiua-6465	15	1	his	his	PRON
aiua-6465	15	2	ipss	ipss	PROPN
aiua-6465	15	3	score	score	NOUN
aiua-6465	15	4	was	be	AUX
aiua-6465	15	5	21	21	NUM
aiua-6465	15	6	and	and	CCONJ
aiua-6465	15	7	he	he	PRON
aiua-6465	15	8	also	also	ADV
aiua-6465	15	9	had	have	VERB
aiua-6465	15	10	an	an	DET
aiua-6465	15	11	abnormal	abnormal	ADJ
aiua-6465	15	12	uroflow	uroflow	NOUN
aiua-6465	15	13	with	with	ADP
aiua-6465	15	14	a	a	DET
aiua-6465	15	15	maximum	maximum	ADJ
aiua-6465	15	16	flow	flow	NOUN
aiua-6465	15	17	of	of	ADP
aiua-6465	15	18	8	8	NUM
aiua-6465	15	19	ml	ml	NOUN
aiua-6465	15	20	/	/	SYM
aiua-6465	15	21	sec	sec	PROPN
aiua-6465	15	22	.	.	PUNCT
aiua-6465	16	1	his	his	PRON
aiua-6465	16	2	serum	serum	NOUN
aiua-6465	16	3	prostate	prostate	NOUN
aiua-6465	16	4	-	-	PUNCT
aiua-6465	16	5	specific	specific	ADJ
aiua-6465	16	6	antigen	antigen	NOUN
aiua-6465	16	7	was	be	AUX
aiua-6465	16	8	1.4	1.4	NUM
aiua-6465	16	9	ng	ng	NOUN
aiua-6465	16	10	/	/	SYM
aiua-6465	16	11	ml	ml	PROPN
aiua-6465	16	12	.	.	PUNCT
aiua-6465	17	1	ultrasonography	ultrasonography	NOUN
aiua-6465	17	2	showed	show	VERB
aiua-6465	17	3	an	an	DET
aiua-6465	17	4	intravesical	intravesical	ADJ
aiua-6465	17	5	prostate	prostate	NOUN
aiua-6465	17	6	protrusion	protrusion	NOUN
aiua-6465	17	7	.	.	PUNCT
aiua-6465	18	1	after	after	ADP
aiua-6465	18	2	six	six	NUM
aiua-6465	18	3	months	month	NOUN
aiua-6465	18	4	of	of	ADP
aiua-6465	18	5	treatment	treatment	NOUN
aiua-6465	18	6	with	with	ADP
aiua-6465	18	7	dutasteride	dutasteride	NOUN
aiua-6465	18	8	the	the	DET
aiua-6465	18	9	patient	patient	NOUN
aiua-6465	18	10	suffered	suffer	VERB
aiua-6465	18	11	from	from	ADP
aiua-6465	18	12	an	an	DET
aiua-6465	18	13	acute	acute	ADJ
aiua-6465	18	14	urinary	urinary	ADJ
aiua-6465	18	15	retention	retention	NOUN
aiua-6465	18	16	,	,	PUNCT
aiua-6465	18	17	which	which	PRON
aiua-6465	18	18	was	be	AUX
aiua-6465	18	19	treated	treat	VERB
aiua-6465	18	20	with	with	ADP
aiua-6465	18	21	suprapubic	suprapubic	ADJ
aiua-6465	18	22	catheter	catheter	NOUN
aiua-6465	18	23	placement	placement	NOUN
aiua-6465	18	24	,	,	PUNCT
aiua-6465	18	25	due	due	ADP
aiua-6465	18	26	to	to	ADP
aiua-6465	18	27	transurethral	transurethral	ADJ
aiua-6465	18	28	catheterization	catheterization	NOUN
aiua-6465	18	29	failure	failure	NOUN
aiua-6465	18	30	.	.	PUNCT
aiua-6465	19	1	preoperatively	preoperatively	ADV
aiua-6465	19	2	his	his	PRON
aiua-6465	19	3	blood	blood	NOUN
aiua-6465	19	4	count	count	NOUN
aiua-6465	19	5	was	be	AUX
aiua-6465	19	6	pathological	pathological	ADJ
aiua-6465	19	7	with	with	ADP
aiua-6465	19	8	37.000	37.000	NUM
aiua-6465	19	9	/	/	SYM
aiua-6465	19	10	mm3	mm3	NOUN
aiua-6465	19	11	wbc	wbc	PROPN
aiua-6465	19	12	.	.	PUNCT
aiua-6465	20	1	he	he	PRON
aiua-6465	20	2	underwent	undergo	VERB
aiua-6465	20	3	transurethral	transurethral	ADJ
aiua-6465	20	4	prostate	prostate	NOUN
aiua-6465	20	5	resection	resection	NOUN
aiua-6465	20	6	and	and	CCONJ
aiua-6465	20	7	the	the	DET
aiua-6465	20	8	postoperative	postoperative	ADJ
aiua-6465	20	9	course	course	NOUN
aiua-6465	20	10	was	be	AUX
aiua-6465	20	11	uneventful	uneventful	ADJ
aiua-6465	20	12	.	.	PUNCT
aiua-6465	21	1	he	he	PRON
aiua-6465	21	2	was	be	AUX
aiua-6465	21	3	dismissed	dismiss	VERB
aiua-6465	21	4	after	after	ADP
aiua-6465	21	5	a	a	DET
aiua-6465	21	6	three	three	NUM
aiua-6465	21	7	-	-	PUNCT
aiua-6465	21	8	day	day	NOUN
aiua-6465	21	9	hospitalization	hospitalization	NOUN
aiua-6465	21	10	with	with	ADP
aiua-6465	21	11	35	35	NUM
aiua-6465	21	12	ml	ml	NOUN
aiua-6465	21	13	of	of	ADP
aiua-6465	21	14	post	post	VERB
aiua-6465	21	15	voiding	void	VERB
aiua-6465	21	16	residual	residual	ADJ
aiua-6465	21	17	.	.	PUNCT
aiua-6465	22	1	histological	histological	ADJ
aiua-6465	22	2	examination	examination	NOUN
aiua-6465	22	3	showed	show	VERB
aiua-6465	22	4	that	that	SCONJ
aiua-6465	22	5	some	some	PRON
aiua-6465	22	6	of	of	ADP
aiua-6465	22	7	the	the	DET
aiua-6465	22	8	prostate	prostate	NOUN
aiua-6465	22	9	chips	chip	NOUN
aiua-6465	22	10	were	be	AUX
aiua-6465	22	11	infiltrated	infiltrate	VERB
aiua-6465	22	12	by	by	ADP
aiua-6465	22	13	lymphocyte	lymphocyte	ADJ
aiua-6465	22	14	cells	cell	NOUN
aiua-6465	22	15	(	(	PUNCT
aiua-6465	22	16	figure	figure	NOUN
aiua-6465	22	17	1	1	NUM
aiua-6465	22	18	)	)	PUNCT
aiua-6465	22	19	.	.	PUNCT
aiua-6465	23	1	that	that	DET
aiua-6465	23	2	cell	cell	NOUN
aiua-6465	23	3	population	population	NOUN
aiua-6465	23	4	was	be	AUX
aiua-6465	23	5	composed	compose	VERB
aiua-6465	23	6	by	by	ADP
aiua-6465	23	7	mainly	mainly	ADV
aiua-6465	23	8	small	small	ADJ
aiua-6465	23	9	cells	cell	NOUN
aiua-6465	23	10	without	without	ADP
aiua-6465	23	11	proliferation	proliferation	NOUN
aiua-6465	23	12	centers	center	NOUN
aiua-6465	23	13	.	.	PUNCT
aiua-6465	24	1	the	the	DET
aiua-6465	24	2	presence	presence	NOUN
aiua-6465	24	3	of	of	ADP
aiua-6465	24	4	a	a	DET
aiua-6465	24	5	few	few	ADJ
aiua-6465	24	6	larger	large	ADJ
aiua-6465	24	7	cell	cell	NOUN
aiua-6465	24	8	types	type	NOUN
aiua-6465	24	9	was	be	AUX
aiua-6465	24	10	also	also	ADV
aiua-6465	24	11	noticed	notice	VERB
aiua-6465	24	12	.	.	PUNCT
aiua-6465	25	1	immunohistochemistry	immunohistochemistry	PROPN
aiua-6465	25	2	showed	show	VERB
aiua-6465	25	3	that	that	SCONJ
aiua-6465	25	4	this	this	DET
aiua-6465	25	5	lymphocyte	lymphocyte	ADJ
aiua-6465	25	6	population	population	NOUN
aiua-6465	25	7	was	be	AUX
aiua-6465	25	8	positive	positive	ADJ
aiua-6465	25	9	in	in	ADP
aiua-6465	25	10	staining	stain	VERB
aiua-6465	25	11	for	for	ADP
aiua-6465	25	12	cd20	cd20	PROPN
aiua-6465	25	13	,	,	PUNCT
aiua-6465	25	14	cd5	cd5	PROPN
aiua-6465	25	15	,	,	PUNCT
aiua-6465	25	16	cd23	cd23	PROPN
aiua-6465	25	17	and	and	CCONJ
aiua-6465	25	18	negative	negative	ADJ
aiua-6465	25	19	for	for	ADP
aiua-6465	25	20	cyclind1	cyclind1	NOUN
aiua-6465	25	21	and	and	CCONJ
aiua-6465	25	22	cd3	cd3	PROPN
aiua-6465	25	23	(	(	PUNCT
aiua-6465	25	24	figure	figure	NOUN
aiua-6465	25	25	1	1	NUM
aiua-6465	25	26	)	)	PUNCT
aiua-6465	25	27	.	.	PUNCT
aiua-6465	26	1	b	b	X
aiua-6465	26	2	-	-	PUNCT
aiua-6465	26	3	lymphocytic	lymphocytic	ADJ
aiua-6465	26	4	infiltration	infiltration	NOUN
aiua-6465	26	5	of	of	ADP
aiua-6465	26	6	the	the	DET
aiua-6465	26	7	prostate	prostate	NOUN
aiua-6465	26	8	was	be	AUX
aiua-6465	26	9	consistent	consistent	ADJ
aiua-6465	26	10	with	with	ADP
aiua-6465	26	11	patients	patient	NOUN
aiua-6465	26	12	’	'	PUNCT
aiua-6465	26	13	history	history	NOUN
aiua-6465	26	14	of	of	ADP
aiua-6465	26	15	chronic	chronic	ADJ
aiua-6465	26	16	lymphocytic	lymphocytic	ADJ
aiua-6465	26	17	leukemia	leukemia	NOUN
aiua-6465	26	18	.	.	PUNCT
aiua-6465	27	1	patient	patient	NOUN
aiua-6465	27	2	was	be	AUX
aiua-6465	27	3	then	then	ADV
aiua-6465	27	4	referred	refer	VERB
aiua-6465	27	5	for	for	ADP
aiua-6465	27	6	oncology	oncology	NOUN
aiua-6465	27	7	reevaluation	reevaluation	NOUN
aiua-6465	27	8	and	and	CCONJ
aiua-6465	27	9	followed	follow	VERB
aiua-6465	27	10	a	a	DET
aiua-6465	27	11	therapeutic	therapeutic	ADJ
aiua-6465	27	12	protocol	protocol	NOUN
aiua-6465	27	13	with	with	ADP
aiua-6465	27	14	filgrastim	filgrastim	ADJ
aiua-6465	27	15	,	,	PUNCT
aiua-6465	27	16	epo	epo	PROPN
aiua-6465	27	17	and	and	CCONJ
aiua-6465	27	18	rituximab	rituximab	NOUN
aiua-6465	27	19	.	.	PUNCT
aiua-6465	28	1	doi	doi	NOUN
aiua-6465	28	2	:	:	PUNCT
aiua-6465	28	3	10.4081	10.4081	NUM
aiua-6465	28	4	/	/	SYM
aiua-6465	28	5	aiua.2017.1.83	aiua.2017.1.83	NOUN
aiua-6465	28	6	introduction	introduction	NOUN
aiua-6465	28	7	hematological	hematological	ADJ
aiua-6465	28	8	diseases	disease	NOUN
aiua-6465	28	9	such	such	ADJ
aiua-6465	28	10	as	as	ADP
aiua-6465	28	11	lymphomas	lymphoma	NOUN
aiua-6465	28	12	and	and	CCONJ
aiua-6465	28	13	chronic	chronic	ADJ
aiua-6465	28	14	lymphocytic	lymphocytic	ADJ
aiua-6465	28	15	leukemia	leukemia	NOUN
aiua-6465	28	16	rarely	rarely	ADV
aiua-6465	28	17	include	include	VERB
aiua-6465	28	18	the	the	DET
aiua-6465	28	19	prostate	prostate	NOUN
aiua-6465	28	20	gland	gland	NOUN
aiua-6465	28	21	as	as	ADP
aiua-6465	28	22	an	an	DET
aiua-6465	28	23	extranodal	extranodal	ADJ
aiua-6465	28	24	manifestation	manifestation	NOUN
aiua-6465	28	25	and	and	CCONJ
aiua-6465	28	26	even	even	ADV
aiua-6465	28	27	rarer	rarer	ADV
aiua-6465	28	28	is	be	AUX
aiua-6465	28	29	their	their	PRON
aiua-6465	28	30	first	first	ADJ
aiua-6465	28	31	appearance	appearance	NOUN
aiua-6465	28	32	to	to	PART
aiua-6465	28	33	be	be	AUX
aiua-6465	28	34	in	in	ADP
aiua-6465	28	35	the	the	DET
aiua-6465	28	36	lower	low	ADJ
aiua-6465	28	37	urinary	urinary	ADJ
aiua-6465	28	38	tract	tract	NOUN
aiua-6465	28	39	.	.	PUNCT
aiua-6465	29	1	we	we	PRON
aiua-6465	29	2	present	present	VERB
aiua-6465	29	3	a	a	DET
aiua-6465	29	4	61	61	NUM
aiua-6465	29	5	years	year	NOUN
aiua-6465	29	6	old	old	ADJ
aiua-6465	29	7	patient	patient	NOUN
aiua-6465	29	8	with	with	ADP
aiua-6465	29	9	a	a	DET
aiua-6465	29	10	history	history	NOUN
aiua-6465	29	11	of	of	ADP
aiua-6465	29	12	chronic	chronic	ADJ
aiua-6465	29	13	lymphocytic	lymphocytic	ADJ
aiua-6465	29	14	leukemia	leukemia	NOUN
aiua-6465	29	15	who	who	PRON
aiua-6465	29	16	underwent	undergo	VERB
aiua-6465	29	17	transurethral	transurethral	ADJ
aiua-6465	29	18	resection	resection	NOUN
aiua-6465	29	19	of	of	ADP
aiua-6465	29	20	prostate	prostate	NOUN
aiua-6465	29	21	adenoma	adenoma	ADJ
aiua-6465	29	22	(	(	PUNCT
aiua-6465	29	23	tur	tur	X
aiua-6465	29	24	-	-	ADJ
aiua-6465	29	25	p	p	NOUN
aiua-6465	29	26	)	)	PUNCT
aiua-6465	29	27	due	due	ADP
aiua-6465	29	28	to	to	ADP
aiua-6465	29	29	an	an	DET
aiua-6465	29	30	acute	acute	ADJ
aiua-6465	29	31	urinary	urinary	ADJ
aiua-6465	29	32	retention	retention	NOUN
aiua-6465	29	33	.	.	PUNCT
aiua-6465	30	1	histological	histological	ADJ
aiua-6465	30	2	examination	examination	NOUN
aiua-6465	30	3	showed	show	VERB
aiua-6465	30	4	low	low	ADJ
aiua-6465	30	5	b	b	NOUN
aiua-6465	30	6	-	-	ADJ
aiua-6465	30	7	lymphocytic	lymphocytic	ADJ
aiua-6465	30	8	infiltration	infiltration	NOUN
aiua-6465	30	9	of	of	ADP
aiua-6465	30	10	the	the	DET
aiua-6465	30	11	prostate	prostate	NOUN
aiua-6465	30	12	parenchyma	parenchyma	NOUN
aiua-6465	30	13	of	of	ADP
aiua-6465	30	14	mainly	mainly	ADV
aiua-6465	30	15	small	small	ADJ
aiua-6465	30	16	lymphocytes	lymphocyte	NOUN
aiua-6465	30	17	.	.	PUNCT
aiua-6465	31	1	case	case	NOUN
aiua-6465	31	2	report	report	VERB
aiua-6465	31	3	a	a	DET
aiua-6465	31	4	61	61	NUM
aiua-6465	31	5	years	year	NOUN
aiua-6465	31	6	old	old	ADJ
aiua-6465	31	7	patient	patient	NOUN
aiua-6465	31	8	with	with	ADP
aiua-6465	31	9	a	a	DET
aiua-6465	31	10	history	history	NOUN
aiua-6465	31	11	of	of	ADP
aiua-6465	31	12	chronic	chronic	ADJ
aiua-6465	31	13	lymphocytic	lymphocytic	ADJ
aiua-6465	31	14	leukemia	leukemia	NOUN
aiua-6465	31	15	,	,	PUNCT
aiua-6465	31	16	figure	figure	NOUN
aiua-6465	31	17	1	1	NUM
aiua-6465	31	18	.	.	PUNCT
aiua-6465	31	19	positive	positive	ADJ
aiua-6465	31	20	staining	staining	NOUN
aiua-6465	31	21	for	for	ADP
aiua-6465	31	22	cd5	cd5	PROPN
aiua-6465	31	23	,	,	PUNCT
aiua-6465	31	24	cd20	cd20	PROPN
aiua-6465	31	25	and	and	CCONJ
aiua-6465	31	26	cd23	cd23	PROPN
aiua-6465	31	27	respectively	respectively	ADV
aiua-6465	31	28	.	.	PUNCT
aiua-6465	32	1	anastasiou_stesura	anastasiou_stesura	NOUN
aiua-6465	32	2	seveso	seveso	PROPN
aiua-6465	32	3	04/04/17	04/04/17	PROPN
aiua-6465	32	4	09:32	09:32	NUM
aiua-6465	32	5	pagina	pagina	NOUN
aiua-6465	32	6	83	83	NUM
aiua-6465	32	7	archivio	archivio	NOUN
aiua-6465	32	8	italiano	italiano	X
aiua-6465	32	9	di	di	X
aiua-6465	32	10	urologia	urologia	PROPN
aiua-6465	32	11	e	e	PROPN
aiua-6465	32	12	andrologia	andrologia	NOUN
aiua-6465	32	13	2017	2017	NUM
aiua-6465	32	14	;	;	PUNCT
aiua-6465	32	15	89	89	NUM
aiua-6465	32	16	,	,	PUNCT
aiua-6465	32	17	1	1	NUM
aiua-6465	32	18	i.	i.	NOUN
aiua-6465	32	19	anastasiou	anastasiou	PROPN
aiua-6465	32	20	,	,	PUNCT
aiua-6465	32	21	s.	s.	PROPN
aiua-6465	32	22	skoufias	skoufias	PROPN
aiua-6465	32	23	,	,	PUNCT
aiua-6465	32	24	i.	i.	PROPN
aiua-6465	32	25	katafigiotis	katafigiotis	PROPN
aiua-6465	32	26	,	,	PUNCT
aiua-6465	32	27	i.	i.	PROPN
aiua-6465	32	28	skarmoutsos	skarmoutsos	PROPN
aiua-6465	32	29	,	,	PUNCT
aiua-6465	32	30	c.a	c.a	PROPN
aiua-6465	32	31	.	.	PROPN
aiua-6465	32	32	constantinides	constantinide	VERB
aiua-6465	32	33	84	84	NUM
aiua-6465	32	34	discussion	discussion	NOUN
aiua-6465	32	35	extra	extra	ADJ
aiua-6465	32	36	-	-	ADJ
aiua-6465	32	37	nodal	nodal	ADJ
aiua-6465	32	38	localization	localization	NOUN
aiua-6465	32	39	of	of	ADP
aiua-6465	32	40	hematological	hematological	ADJ
aiua-6465	32	41	diseases	disease	NOUN
aiua-6465	32	42	,	,	PUNCT
aiua-6465	32	43	such	such	ADJ
aiua-6465	32	44	as	as	ADP
aiua-6465	32	45	chronic	chronic	ADJ
aiua-6465	32	46	lymphocytic	lymphocytic	ADJ
aiua-6465	32	47	leukemia	leukemia	NOUN
aiua-6465	32	48	and	and	CCONJ
aiua-6465	32	49	lymphomas	lymphoma	NOUN
aiua-6465	32	50	rarely	rarely	ADV
aiua-6465	32	51	regards	regard	VERB
aiua-6465	32	52	the	the	DET
aiua-6465	32	53	genitourinary	genitourinary	ADJ
aiua-6465	32	54	tract	tract	NOUN
aiua-6465	32	55	and	and	CCONJ
aiua-6465	32	56	especially	especially	ADV
aiua-6465	32	57	prostate	prostate	NOUN
aiua-6465	32	58	gland	gland	NOUN
aiua-6465	32	59	(	(	PUNCT
aiua-6465	32	60	1	1	NUM
aiua-6465	32	61	)	)	PUNCT
aiua-6465	32	62	.	.	PUNCT
aiua-6465	33	1	in	in	ADP
aiua-6465	33	2	the	the	DET
aiua-6465	33	3	majority	majority	NOUN
aiua-6465	33	4	of	of	ADP
aiua-6465	33	5	cases	case	NOUN
aiua-6465	33	6	leukemic	leukemic	ADJ
aiua-6465	33	7	infiltration	infiltration	NOUN
aiua-6465	33	8	of	of	ADP
aiua-6465	33	9	the	the	DET
aiua-6465	33	10	prostate	prostate	NOUN
aiua-6465	33	11	is	be	AUX
aiua-6465	33	12	asymptomatic	asymptomatic	ADJ
aiua-6465	33	13	and	and	CCONJ
aiua-6465	33	14	serum	serum	VERB
aiua-6465	33	15	prostate	prostate	NOUN
aiua-6465	33	16	-	-	PUNCT
aiua-6465	33	17	specific	specific	ADJ
aiua-6465	33	18	antigen	antigen	ADJ
aiua-6465	33	19	level	level	NOUN
aiua-6465	33	20	is	be	AUX
aiua-6465	33	21	usually	usually	ADV
aiua-6465	33	22	normal	normal	ADJ
aiua-6465	33	23	.	.	PUNCT
aiua-6465	34	1	acute	acute	ADJ
aiua-6465	34	2	urinary	urinary	ADJ
aiua-6465	34	3	retention	retention	NOUN
aiua-6465	34	4	is	be	AUX
aiua-6465	34	5	also	also	ADV
aiua-6465	34	6	rare	rare	ADJ
aiua-6465	34	7	,	,	PUNCT
aiua-6465	34	8	whilst	whilst	SCONJ
aiua-6465	34	9	in	in	ADP
aiua-6465	34	10	most	most	ADJ
aiua-6465	34	11	of	of	ADP
aiua-6465	34	12	the	the	DET
aiua-6465	34	13	cases	case	NOUN
aiua-6465	34	14	prostate	prostate	NOUN
aiua-6465	34	15	gland	gland	NOUN
aiua-6465	34	16	is	be	AUX
aiua-6465	34	17	not	not	PART
aiua-6465	34	18	enlarged	enlarge	VERB
aiua-6465	34	19	,	,	PUNCT
aiua-6465	34	20	and	and	CCONJ
aiua-6465	34	21	digital	digital	ADJ
aiua-6465	34	22	rectal	rectal	ADJ
aiua-6465	34	23	examination	examination	NOUN
aiua-6465	34	24	mostly	mostly	ADV
aiua-6465	34	25	reveals	reveal	VERB
aiua-6465	34	26	a	a	DET
aiua-6465	34	27	rubbery	rubbery	ADJ
aiua-6465	34	28	,	,	PUNCT
aiua-6465	34	29	firm	firm	ADJ
aiua-6465	34	30	,	,	PUNCT
aiua-6465	34	31	gland	gland	NOUN
aiua-6465	34	32	(	(	PUNCT
aiua-6465	34	33	2	2	NUM
aiua-6465	34	34	)	)	PUNCT
aiua-6465	34	35	.	.	PUNCT
aiua-6465	35	1	transabdominal	transabdominal	NOUN
aiua-6465	35	2	and	and	CCONJ
aiua-6465	35	3	transrectal	transrectal	ADJ
aiua-6465	35	4	ultrasound	ultrasound	NOUN
aiua-6465	35	5	examination	examination	NOUN
aiua-6465	35	6	may	may	AUX
aiua-6465	35	7	reveal	reveal	VERB
aiua-6465	35	8	some	some	DET
aiua-6465	35	9	hypoechoic	hypoechoic	ADJ
aiua-6465	35	10	zones	zone	NOUN
aiua-6465	35	11	but	but	CCONJ
aiua-6465	35	12	these	these	PRON
aiua-6465	35	13	are	be	AUX
aiua-6465	35	14	not	not	PART
aiua-6465	35	15	specific	specific	ADJ
aiua-6465	35	16	signs	sign	NOUN
aiua-6465	35	17	.	.	PUNCT
aiua-6465	36	1	clinical	clinical	ADJ
aiua-6465	36	2	diagnosis	diagnosis	NOUN
aiua-6465	36	3	is	be	AUX
aiua-6465	36	4	difficult	difficult	ADJ
aiua-6465	36	5	to	to	PART
aiua-6465	36	6	made	make	VERB
aiua-6465	36	7	before	before	ADP
aiua-6465	36	8	surgery	surgery	NOUN
aiua-6465	36	9	in	in	ADP
aiua-6465	36	10	patients	patient	NOUN
aiua-6465	36	11	without	without	ADP
aiua-6465	36	12	any	any	DET
aiua-6465	36	13	history	history	NOUN
aiua-6465	36	14	of	of	ADP
aiua-6465	36	15	malignancy	malignancy	NOUN
aiua-6465	36	16	.	.	PUNCT
aiua-6465	37	1	however	however	ADV
aiua-6465	37	2	in	in	ADP
aiua-6465	37	3	patients	patient	NOUN
aiua-6465	37	4	with	with	ADP
aiua-6465	37	5	a	a	DET
aiua-6465	37	6	known	know	VERB
aiua-6465	37	7	history	history	NOUN
aiua-6465	37	8	of	of	ADP
aiua-6465	37	9	hematological	hematological	ADJ
aiua-6465	37	10	disease	disease	NOUN
aiua-6465	37	11	,	,	PUNCT
aiua-6465	37	12	luts	luts	PROPN
aiua-6465	37	13	might	might	AUX
aiua-6465	37	14	be	be	AUX
aiua-6465	37	15	indicative	indicative	ADJ
aiua-6465	37	16	of	of	ADP
aiua-6465	37	17	prostate	prostate	NOUN
aiua-6465	37	18	infiltration	infiltration	NOUN
aiua-6465	37	19	despite	despite	SCONJ
aiua-6465	37	20	the	the	DET
aiua-6465	37	21	fact	fact	NOUN
aiua-6465	37	22	,	,	PUNCT
aiua-6465	37	23	that	that	DET
aiua-6465	37	24	prostate	prostate	NOUN
aiua-6465	37	25	gland	gland	NOUN
aiua-6465	37	26	is	be	AUX
aiua-6465	37	27	not	not	PART
aiua-6465	37	28	a	a	DET
aiua-6465	37	29	common	common	ADJ
aiua-6465	37	30	non	non	ADJ
aiua-6465	37	31	-	-	ADJ
aiua-6465	37	32	hematopoietic	hematopoietic	ADJ
aiua-6465	37	33	site	site	NOUN
aiua-6465	37	34	of	of	ADP
aiua-6465	37	35	neoplastic	neoplastic	ADJ
aiua-6465	37	36	cells	cell	NOUN
aiua-6465	37	37	spreading	spread	VERB
aiua-6465	37	38	(	(	PUNCT
aiua-6465	37	39	3	3	NUM
aiua-6465	37	40	)	)	PUNCT
aiua-6465	37	41	.	.	PUNCT
aiua-6465	38	1	tur	tur	X
aiua-6465	38	2	-	-	PUNCT
aiua-6465	38	3	p	p	NOUN
aiua-6465	38	4	is	be	AUX
aiua-6465	38	5	usually	usually	ADV
aiua-6465	38	6	performed	perform	VERB
aiua-6465	38	7	to	to	PART
aiua-6465	38	8	diagnose	diagnose	VERB
aiua-6465	38	9	and	and	CCONJ
aiua-6465	38	10	release	release	VERB
aiua-6465	38	11	clinical	clinical	ADJ
aiua-6465	38	12	symptoms	symptom	NOUN
aiua-6465	38	13	due	due	ADP
aiua-6465	38	14	to	to	ADP
aiua-6465	38	15	lower	low	ADJ
aiua-6465	38	16	urinary	urinary	ADJ
aiua-6465	38	17	tract	tract	NOUN
aiua-6465	38	18	obstruction	obstruction	NOUN
aiua-6465	38	19	(	(	PUNCT
aiua-6465	38	20	1	1	NUM
aiua-6465	38	21	)	)	PUNCT
aiua-6465	38	22	.	.	PUNCT
aiua-6465	39	1	chronic	chronic	ADJ
aiua-6465	39	2	lymphocytic	lymphocytic	ADJ
aiua-6465	39	3	leukemia	leukemia	NOUN
aiua-6465	39	4	,	,	PUNCT
aiua-6465	39	5	as	as	SCONJ
aiua-6465	39	6	a	a	DET
aiua-6465	39	7	disease	disease	NOUN
aiua-6465	39	8	of	of	ADP
aiua-6465	39	9	the	the	DET
aiua-6465	39	10	elderly	elderly	ADJ
aiua-6465	39	11	often	often	ADV
aiua-6465	39	12	coexists	coexist	VERB
aiua-6465	39	13	with	with	ADP
aiua-6465	39	14	bph	bph	NOUN
aiua-6465	39	15	and	and	CCONJ
aiua-6465	39	16	symptoms	symptom	NOUN
aiua-6465	39	17	usually	usually	ADV
aiua-6465	39	18	do	do	AUX
aiua-6465	39	19	n’t	not	PART
aiua-6465	39	20	subside	subside	VERB
aiua-6465	39	21	with	with	ADP
aiua-6465	39	22	medical	medical	ADJ
aiua-6465	39	23	therapy	therapy	NOUN
aiua-6465	39	24	such	such	ADJ
aiua-6465	39	25	as	as	ADP
aiua-6465	39	26	α	α	NOUN
aiua-6465	39	27	-	-	NOUN
aiua-6465	39	28	blockers	blocker	NOUN
aiua-6465	39	29	and	and	CCONJ
aiua-6465	39	30	5α	5α	ADJ
aiua-6465	39	31	reductase	reductase	NOUN
aiua-6465	39	32	inhibitors	inhibitor	NOUN
aiua-6465	39	33	.	.	PUNCT
aiua-6465	40	1	final	final	ADJ
aiua-6465	40	2	diagnosis	diagnosis	NOUN
aiua-6465	40	3	is	be	AUX
aiua-6465	40	4	set	set	VERB
aiua-6465	40	5	by	by	ADP
aiua-6465	40	6	histopathology	histopathology	NOUN
aiua-6465	40	7	examination	examination	NOUN
aiua-6465	40	8	and	and	CCONJ
aiua-6465	40	9	immunohistochemistry	immunohistochemistry	NOUN
aiua-6465	40	10	.	.	PUNCT
aiua-6465	41	1	the	the	DET
aiua-6465	41	2	prognosis	prognosis	NOUN
aiua-6465	41	3	of	of	ADP
aiua-6465	41	4	these	these	DET
aiua-6465	41	5	patients	patient	NOUN
aiua-6465	41	6	is	be	AUX
aiua-6465	41	7	related	relate	VERB
aiua-6465	41	8	to	to	ADP
aiua-6465	41	9	the	the	DET
aiua-6465	41	10	generalized	generalized	ADJ
aiua-6465	41	11	disease	disease	NOUN
aiua-6465	41	12	rather	rather	ADV
aiua-6465	41	13	than	than	ADP
aiua-6465	41	14	to	to	ADP
aiua-6465	41	15	the	the	DET
aiua-6465	41	16	prostatic	prostatic	ADJ
aiua-6465	41	17	involvement	involvement	NOUN
aiua-6465	41	18	.	.	PUNCT
aiua-6465	42	1	oncological	oncological	ADJ
aiua-6465	42	2	refer	refer	NOUN
aiua-6465	42	3	is	be	AUX
aiua-6465	42	4	necessary	necessary	ADJ
aiua-6465	42	5	and	and	CCONJ
aiua-6465	42	6	most	most	ADJ
aiua-6465	42	7	of	of	ADP
aiua-6465	42	8	the	the	DET
aiua-6465	42	9	times	time	NOUN
aiua-6465	42	10	,	,	PUNCT
aiua-6465	42	11	patients	patient	NOUN
aiua-6465	42	12	follow	follow	VERB
aiua-6465	42	13	therapy	therapy	NOUN
aiua-6465	42	14	protocols	protocol	NOUN
aiua-6465	42	15	after	after	ADP
aiua-6465	42	16	the	the	DET
aiua-6465	42	17	confirmation	confirmation	NOUN
aiua-6465	42	18	of	of	ADP
aiua-6465	42	19	leukemia	leukemia	NOUN
aiua-6465	42	20	secondary	secondary	ADJ
aiua-6465	42	21	involvement	involvement	NOUN
aiua-6465	42	22	.	.	PUNCT
aiua-6465	43	1	conclusions	conclusion	NOUN
aiua-6465	43	2	although	although	SCONJ
aiua-6465	43	3	it	it	PRON
aiua-6465	43	4	is	be	AUX
aiua-6465	43	5	rare	rare	ADJ
aiua-6465	43	6	,	,	PUNCT
aiua-6465	43	7	genitourinary	genitourinary	ADJ
aiua-6465	43	8	tract	tract	NOUN
aiua-6465	43	9	can	can	AUX
aiua-6465	43	10	be	be	AUX
aiua-6465	43	11	an	an	DET
aiua-6465	43	12	extranodal	extranodal	ADJ
aiua-6465	43	13	site	site	NOUN
aiua-6465	43	14	of	of	ADP
aiua-6465	43	15	chronic	chronic	ADJ
aiua-6465	43	16	lymphocytic	lymphocytic	ADJ
aiua-6465	43	17	leukemia	leukemia	NOUN
aiua-6465	43	18	.	.	PUNCT
aiua-6465	44	1	therefore	therefore	ADV
aiua-6465	44	2	the	the	DET
aiua-6465	44	3	differential	differential	ADJ
aiua-6465	44	4	diagnosis	diagnosis	NOUN
aiua-6465	44	5	should	should	AUX
aiua-6465	44	6	always	always	ADV
aiua-6465	44	7	include	include	VERB
aiua-6465	44	8	the	the	DET
aiua-6465	44	9	infiltration	infiltration	NOUN
aiua-6465	44	10	of	of	ADP
aiua-6465	44	11	the	the	DET
aiua-6465	44	12	prostate	prostate	NOUN
aiua-6465	44	13	gland	gland	NOUN
aiua-6465	44	14	by	by	ADP
aiua-6465	44	15	lymphocyte	lymphocyte	ADJ
aiua-6465	44	16	cells	cell	NOUN
aiua-6465	44	17	.	.	PUNCT
aiua-6465	45	1	awareness	awareness	NOUN
aiua-6465	45	2	is	be	AUX
aiua-6465	45	3	needed	need	VERB
aiua-6465	45	4	in	in	ADP
aiua-6465	45	5	the	the	DET
aiua-6465	45	6	elderly	elderly	ADJ
aiua-6465	45	7	men	man	NOUN
aiua-6465	45	8	with	with	ADP
aiua-6465	45	9	hematological	hematological	ADJ
aiua-6465	45	10	disease	disease	NOUN
aiua-6465	45	11	despite	despite	SCONJ
aiua-6465	45	12	the	the	DET
aiua-6465	45	13	fact	fact	NOUN
aiua-6465	45	14	that	that	SCONJ
aiua-6465	45	15	there	there	PRON
aiua-6465	45	16	are	be	VERB
aiua-6465	45	17	no	no	DET
aiua-6465	45	18	specific	specific	ADJ
aiua-6465	45	19	lower	low	ADJ
aiua-6465	45	20	urinary	urinary	ADJ
aiua-6465	45	21	tract	tract	NOUN
aiua-6465	45	22	symptoms	symptom	NOUN
aiua-6465	45	23	to	to	PART
aiua-6465	45	24	indicate	indicate	VERB
aiua-6465	45	25	prostate	prostate	NOUN
aiua-6465	45	26	infiltration	infiltration	NOUN
aiua-6465	45	27	.	.	PUNCT
aiua-6465	46	1	the	the	DET
aiua-6465	46	2	diagnosis	diagnosis	NOUN
aiua-6465	46	3	is	be	AUX
aiua-6465	46	4	always	always	ADV
aiua-6465	46	5	histological	histological	ADJ
aiua-6465	46	6	and	and	CCONJ
aiua-6465	46	7	an	an	DET
aiua-6465	46	8	oncological	oncological	ADJ
aiua-6465	46	9	reevaluation	reevaluation	NOUN
aiua-6465	46	10	is	be	AUX
aiua-6465	46	11	necessary	necessary	ADJ
aiua-6465	46	12	.	.	PUNCT
aiua-6465	47	1	references	reference	NOUN
aiua-6465	47	2	1	1	NUM
aiua-6465	47	3	.	.	PUNCT
aiua-6465	47	4	chu	chu	PROPN
aiua-6465	47	5	pg	pg	PROPN
aiua-6465	47	6	,	,	PUNCT
aiua-6465	47	7	huang	huang	PROPN
aiua-6465	47	8	q	q	PROPN
aiua-6465	47	9	,	,	PUNCT
aiua-6465	47	10	weiss	weiss	PROPN
aiua-6465	47	11	lm	lm	PROPN
aiua-6465	47	12	.	.	PROPN
aiua-6465	47	13	incidental	incidental	ADJ
aiua-6465	47	14	and	and	CCONJ
aiua-6465	47	15	concurrent	concurrent	ADJ
aiua-6465	47	16	malignant	malignant	ADJ
aiua-6465	47	17	lymphomas	lymphoma	NOUN
aiua-6465	47	18	discovered	discover	VERB
aiua-6465	47	19	at	at	ADP
aiua-6465	47	20	the	the	DET
aiua-6465	47	21	time	time	NOUN
aiua-6465	47	22	of	of	ADP
aiua-6465	47	23	prostatectomy	prostatectomy	NOUN
aiua-6465	47	24	and	and	CCONJ
aiua-6465	47	25	prostate	prostate	NOUN
aiua-6465	47	26	biopsy	biopsy	NOUN
aiua-6465	47	27	:	:	PUNCT
aiua-6465	47	28	a	a	DET
aiua-6465	47	29	study	study	NOUN
aiua-6465	47	30	of	of	ADP
aiua-6465	47	31	29	29	NUM
aiua-6465	47	32	cases	case	NOUN
aiua-6465	47	33	.	.	PUNCT
aiua-6465	48	1	am	be	AUX
aiua-6465	48	2	j	j	PROPN
aiua-6465	48	3	surg	surg	PROPN
aiua-6465	48	4	pathol	pathol	NOUN
aiua-6465	48	5	.	.	PUNCT
aiua-6465	49	1	2005	2005	NUM
aiua-6465	49	2	;	;	PUNCT
aiua-6465	49	3	29:693	29:693	NUM
aiua-6465	49	4	-	-	SYM
aiua-6465	49	5	699	699	NUM
aiua-6465	49	6	.	.	NOUN
aiua-6465	50	1	2	2	NUM
aiua-6465	50	2	.	.	PUNCT
aiua-6465	50	3	kassar	kassar	PROPN
aiua-6465	50	4	o	o	PROPN
aiua-6465	50	5	,	,	PUNCT
aiua-6465	50	6	gouiaa	gouiaa	VERB
aiua-6465	50	7	n	n	CCONJ
aiua-6465	50	8	,	,	PUNCT
aiua-6465	50	9	mdhaffar	mdhaffar	PROPN
aiua-6465	50	10	m	m	PROPN
aiua-6465	50	11	,	,	PUNCT
aiua-6465	50	12	et	et	PROPN
aiua-6465	50	13	al	al	PROPN
aiua-6465	50	14	.	.	PROPN
aiua-6465	50	15	primary	primary	ADJ
aiua-6465	50	16	manifestation	manifestation	NOUN
aiua-6465	50	17	of	of	ADP
aiua-6465	50	18	small	small	ADJ
aiua-6465	50	19	lymphocytic	lymphocytic	ADJ
aiua-6465	50	20	lymphoma	lymphoma	NOUN
aiua-6465	50	21	in	in	ADP
aiua-6465	50	22	the	the	DET
aiua-6465	50	23	prostate	prostate	NOUN
aiua-6465	50	24	:	:	PUNCT
aiua-6465	50	25	a	a	DET
aiua-6465	50	26	case	case	NOUN
aiua-6465	50	27	report	report	NOUN
aiua-6465	50	28	.	.	PUNCT
aiua-6465	51	1	tunis	tunis	VERB
aiua-6465	51	2	med	med	PROPN
aiua-6465	51	3	.	.	PROPN
aiua-6465	52	1	2015	2015	NUM
aiua-6465	52	2	;	;	PUNCT
aiua-6465	52	3	93:249	93:249	NUM
aiua-6465	52	4	-	-	SYM
aiua-6465	52	5	58	58	NUM
aiua-6465	52	6	.	.	PUNCT
aiua-6465	53	1	3	3	X
aiua-6465	53	2	.	.	X
aiua-6465	53	3	d’arena	d’arena	PROPN
aiua-6465	53	4	g	g	PROPN
aiua-6465	53	5	,	,	PUNCT
aiua-6465	53	6	guariglia	guariglia	ADJ
aiua-6465	53	7	r	r	NOUN
aiua-6465	53	8	,	,	PUNCT
aiua-6465	53	9	villani	villani	PROPN
aiua-6465	53	10	o	o	PROPN
aiua-6465	53	11	,	,	PUNCT
aiua-6465	53	12	et	et	PROPN
aiua-6465	53	13	al	al	PROPN
aiua-6465	53	14	.	.	PUNCT
aiua-6465	54	1	an	an	DET
aiua-6465	54	2	urologic	urologic	ADJ
aiua-6465	54	3	face	face	NOUN
aiua-6465	54	4	of	of	ADP
aiua-6465	54	5	chronic	chronic	ADJ
aiua-6465	54	6	lymphocytic	lymphocytic	ADJ
aiua-6465	54	7	leukemia	leukemia	NOUN
aiua-6465	54	8	:	:	PUNCT
aiua-6465	54	9	sequential	sequential	ADJ
aiua-6465	54	10	prostatic	prostatic	ADJ
aiua-6465	54	11	and	and	CCONJ
aiua-6465	54	12	penis	penis	NOUN
aiua-6465	54	13	localization	localization	NOUN
aiua-6465	54	14	mediterr	mediterr	NOUN
aiua-6465	54	15	j	j	PROPN
aiua-6465	54	16	hematol	hematol	PROPN
aiua-6465	54	17	infect	infect	VERB
aiua-6465	54	18	dis	dis	PROPN
aiua-6465	54	19	.	.	PUNCT
aiua-6465	54	20	2013	2013	NUM
aiua-6465	54	21	;	;	PUNCT
aiua-6465	54	22	5	5	NUM
aiua-6465	54	23	:	:	PUNCT
aiua-6465	54	24	e2013008	e2013008	NOUN
aiua-6465	54	25	.	.	PUNCT
aiua-6465	54	26	correspondence	correspondence	NOUN
aiua-6465	54	27	ioannis	ioannis	PROPN
aiua-6465	54	28	anastasiou	anastasiou	PROPN
aiua-6465	54	29	,	,	PUNCT
aiua-6465	54	30	md	md	PROPN
aiua-6465	54	31	ekati2@otenet.gr	ekati2@otenet.gr	PROPN
aiua-6465	54	32	spyridon	spyridon	PROPN
aiua-6465	54	33	skoufias	skoufias	PROPN
aiua-6465	54	34	,	,	PUNCT
aiua-6465	54	35	md	md	PROPN
aiua-6465	54	36	spyskouf@hotmail.com	spyskouf@hotmail.com	PROPN
aiua-6465	55	1	ioannis	ioannis	PROPN
aiua-6465	55	2	katafigiotis	katafigiotis	PROPN
aiua-6465	55	3	,	,	PUNCT
aiua-6465	55	4	md	md	PROPN
aiua-6465	55	5	,	,	PUNCT
aiua-6465	55	6	mls	mls	PROPN
aiua-6465	55	7	,	,	PUNCT
aiua-6465	55	8	phd	phd	NOUN
aiua-6465	55	9	,	,	PUNCT
aiua-6465	55	10	febu	febu	NOUN
aiua-6465	55	11	(	(	PUNCT
aiua-6465	55	12	corresponding	corresponding	ADJ
aiua-6465	55	13	author	author	NOUN
aiua-6465	55	14	)	)	PUNCT
aiua-6465	55	15	katafigiotis.giannis@gmail.com	katafigiotis.giannis@gmail.com	PROPN
aiua-6465	55	16	ioannis	ioannis	PROPN
aiua-6465	55	17	skarmoutsos	skarmoutsos	PROPN
aiua-6465	55	18	,	,	PUNCT
aiua-6465	55	19	md	md	PROPN
aiua-6465	55	20	iskarm@gmail.com	iskarm@gmail.com	X
aiua-6465	56	1	constantinos	constantinos	PROPN
aiua-6465	56	2	a.	a.	PROPN
aiua-6465	56	3	constantinides	constantinide	VERB
aiua-6465	56	4	,	,	PUNCT
aiua-6465	56	5	md	md	VERB
aiua-6465	56	6	ckonstan@med.uoa.gr	ckonstan@med.uoa.gr	PROPN
aiua-6465	56	7	1st	1st	PROPN
aiua-6465	56	8	university	university	NOUN
aiua-6465	56	9	urology	urology	NOUN
aiua-6465	56	10	clinic	clinic	NOUN
aiua-6465	56	11	,	,	PUNCT
aiua-6465	56	12	laiko	laiko	ADJ
aiua-6465	56	13	hospital	hospital	NOUN
aiua-6465	56	14	ag.thoma	ag.thoma	NOUN
aiua-6465	56	15	17	17	NUM
aiua-6465	56	16	,	,	PUNCT
aiua-6465	56	17	athens	athens	PROPN
aiua-6465	56	18	11527	11527	NUM
aiua-6465	56	19	greece	greece	PROPN
aiua-6465	56	20	anastasiou_stesura	anastasiou_stesura	PROPN
aiua-6465	56	21	seveso	seveso	PROPN
aiua-6465	56	22	04/04/17	04/04/17	PROPN
aiua-6465	56	23	09:32	09:32	NUM
aiua-6465	56	24	pagina	pagina	NOUN
aiua-6465	56	25	84	84	NUM